Dr. Renske Hesselink currently works as a Senior Scientist Formulation Development at Janssen. She is responsible for the development of stable and effective vaccines against infectious diseases such as Ebola and RSV. Previously, she worked on analytical method development and characterization of vaccines and proteins, giving her a broad knowledge of process, product, and analytical tools.
Renske holds an MSc degree in Molecular Sciences from Wageningen University and a PhD in Membrane Biochemistry from the University of Leeds.